Living with Atopic Dermatitis: Effects beyond the skin’s surface
Head of Living With, Mariel Metcalfe, discusses the nature of Atopic Dermatitis and some key findings from a recent study conducted in Europe
Earlier this year, we published the report “Living with Atopic Dermatitis (AD) EU”, based on primary market research, which reveals key insights and unmet needs from the AD adult and paediatric patient perspective and treatment journey. In December 2017, we published a US report, which is also available to purchase.
Engaging patient advocacy groups: The key to conducting effective rare disease research
This article, published by Pharma Times September 2019, outlines why market researchers should reach out to patient advocacy groups when conducting rare disease research.
Until recently, the size of the market for specific rare diseases had made it difficult for pharmaceutical companies to justify research and development costs. The introduction of regulatory benefits such as longer market exclusivity, breakthrough designations, reduced fees and tax incentives have encouraged more investment. Nevertheless, where funding has been allocated for rare diseases, the scarcity and geographical dispersal of patients can make it difficult to conduct effective market research. Identifying and recruiting respondents is one of the core challenges when conducting research in this space.
The digital patient
Comparing usage and attitudes in mature and emerging markets
We may talk about always putting the patient at the heart of healthcare, but in some less established world markets, is this feasible? The rise of chronic diseases in some regions, combined with an ageing and growing population, is putting unbearable pressure on health-care systems already at capacity.
Research Partnership launches new patient Living with Psoriatic Arthritis (PsA) 2019 EU report
Living with Psoriatic Arthritis is new a report conducted amongst 265 patients in France, Germany, Italy, Spain and UK. The report is based on the findings from 30-minute quantitative online and qualitative telephone interviews with patients. It will provide an update on the existing Living with PsA report published in 2016 and will be available to purchase in October 2019.
Research Partnership publishes new patient Living with Ankylosing Spondylitis & nr-axSpA EU & US 2019 reports
Living with Ankylosing Spondylitis (AS) & nr-AxSpA are reports based on quantitative studies conducted online in the 5EU and US. The AS 5EU report comprises of interviews with 385 patients in France, Germany, Italy, Spain and UK, while the AS US report is based on a study of 136 patients. The Living with nr-AxSpA report comprises of interviews with a total of 78 patients in the 5EU and the US. All of the studies consist of 30-minute quantitative online interviews and for the AS studies 30 minute qualitative tele-depth interviews. The reports are available to purchase in the following formats: AS (5EU), AS (US) and nr-AxSpA (5EU & US).